Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes.
Cortical Damage and Disability in Multiple Sclerosis: Relation to Intracortical Inhibition and Facilitation.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein-Barr virus infection.
Analysis of a Functional IL-6 Gene Polymorphism in HLAB27 Associated and Intermediate Uveitis Gives New Insight in Disease Pathogenesis and Commonality with Other Autoimmune Diseases.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
Co-occurring Depression and Pain in Multiple Sclerosis.
Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy.
Demyelinating CNS Lesions in a Teenager.
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Diagnoses in Pediatric Patients With Magnetic Resonance Imaging (MRI) Lesions Suspicious for Demyelination.
25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study.
Multiple sclerosis and pregnancy; What a neurologist may be asked for?
Literature Commentary.
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire.
Remyelination strategies in multiple sclerosis: a critical reflection.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Neuromyelitis optica (Devic's syndrome).
PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »